Letermovir, initially approved for cytomegalovirus (CMV) prophylaxis in hematopoietic stem-cell transplantation, has gained attention for off-label use in lung-transplant (LTx) recipients. Given the high susceptibility of LTx recipients to CMV infection, this study explores the effectiveness and safety of letermovir prophylaxis. A retrospective analysis of using letermovir for LTx recipients at Tohoku University Hospital (January 2000 to November 2023) was conducted. Case summaries from other Japanese transplant centers and a literature review were included. Six cases at Tohoku University Hospital and one at Kyoto University Hospital were identified. Prophylactic letermovir use showed positive outcomes in managing myelosuppression and preventing CMV replication. The literature review supported the safety of letermovir in high-risk LTx recipients. Despite limited reports, our findings suggest letermovir’s potential as prophylaxis for LTx recipients intolerant to valganciclovir. Safety, especially in managing myelosuppression, positions letermovir as a promising option. However, careful consideration is important in judiciously integrating letermovir into the treatment protocol.
17 May 2022 in Journal of Infection and Chemotherapy
Mycobacterium avium is an intracellular proliferating pathogen that causes chronic refractory respiratory infection. Although apoptosis induced by M. avium has been reported in vitro, the role of apoptosis against M. avium infection in vivo remains unclear. Here, we investigated the role of apoptosis in mouse models of M. avium infection. Tumor necrosis factor receptor-1 knockout mice (TNFR1-KO) andTNFR2-KO micewere used. M. avium (1 × 107 cfu/body) was administered intratracheally to mice. Apoptosis in lungs was detected by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling and lung histology as well as cell death detection kits using BAL fluids. TNFR1-KO mice were susceptible to M. avium infection compared with TNFR2-KO and wild type mice based on the bacterial number and lung histology. Higher numbers of apoptotic cells were detected in the lungs of TNFR2-KO and wild-type mice were compared with TNFR1-KO mice. The inhalation of Z-VAD-FMK deteriorated M. avium infection compared with vehicle-inhaled controls. Overexpression of Iκ-B alpha by adenovirus vector attenuated M. avium infection. Our study showed apoptosis had an important role in innate immunity against M. avium in mice. The induction of apoptosis in M. avium-infected cells might be a new strategy to control M. avium infection.
12 May 2026 in International Journal of Infectious Diseases
Infectious complications remain a major contributor to morbidity and mortality after lung transplantation. In Japan, prolonged waiting periods are a major challenge for lung transplant candidates, during which infection-related risk evolves with new exposures, exacerbations, and hospitalizations. This review provides a practice-oriented approach to infection screening at listing and vaccination management throughout the waiting period for lung transplantation in Japan. Baseline screening at listing is organized into universal serologies, respiratory microbiology (bacteria, moulds, and nontuberculous mycobacteria), reservoir evaluation (e.g., sinonasal and dental foci), and exposure-driven tests. Vaccination should be completed as early as feasible during the waiting period to maximize immunogenicity before immunosuppression, with prioritization of respiratory vaccines and careful assessment of eligibility for live vaccines. Because airway colonization patterns and resistance profiles change over time, respiratory cultures and susceptibilities should be updated through scheduled reassessment, event-driven testing, and pre-transplant confirmation to inform peri-transplant antimicrobial planning. Although centered on Japan, this workflow is intended to be adaptable to donor-limited programs and other regions where prolonged waiting periods necessitate time-based reassessment and prevention.